Ticker
VVOSCompany Name
VIVOS THERAPEUTICS INCSector
HealthcareIndustry
Medical DevicesExchange
NASDAQDate | Gross Profit | Gross Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 8.05M | 55.93% | $ 14.39M |
3/31/2025 | $ 8.59M | 58.73% | $ 14.63M |
12/31/2024 | $ 9.02M | 60% | $ 15.03M |
9/30/2024 | $ 8.86M | 60.76% | $ 14.58M |
6/30/2024 | $ 8.42M | 60.08% | $ 14.02M |
3/31/2024 | $ 7.87M | 58.9% | $ 13.36M |
12/31/2023 | $ 8.27M | 59.93% | $ 13.8M |
9/30/2023 | $ 8.72M | 60.1% | $ 14.5M |
6/30/2023 | $ 9.31M | 60.3% | $ 15.45M |
3/31/2023 | $ 9.8M | 60.39% | $ 16.24M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Revenues
(=) Gross %
Gross % for VIVOS THERAPEUTICS INC is calculated as follows: GP [ $ 8.66M ] / Revenues [ $ 11.39M ]
(=) Gross % [ 75.99% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.8K |
---|---|
min | -72.25% |
max | 150.26% |
average | 53.12% |
median | 49.48% |
std | 31.58% |